English
简体中文
Total: £ 56.28
Published Date: 2024-04-10 | Pages: 81 | Tables: 166 | Pharma & Healthcare
The global Animal Biopharma market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
According to Our PET Supplies Research Center, the global pet industry reached $ 261 billion in 2022, a year-on-year increase of 11.3%. The United States gains the highest pet penetration rate and becomes the largest pet market. According to the American Pet Products Association (APPA), 66% of American households keep pets, and the total industry sales was about US$136.8 billion, an increase of 10.8% over 2021. According to IVH, the German pet products industry association, the number of pets in Germany reached 33.4 million in 2022, with a total turnover of nearly €6.5 billion. The 2023 China Pet Industry Trend Insight White Paper released by JD shows that the market size of the four major pet physical commodities is increasing year by year: pet supplies account for 45%, pet staple food accounts for nearly 35%, pet snacks account for 12%, and pet medicine and health care account for 143%.
This report aims to provide a comprehensive presentation of the global market for Animal Biopharma, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Animal Biopharma.
Report Scope
The Animal Biopharma market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Animal Biopharma market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Animal Biopharma companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Boehringer Ingelheim
Invetx
CZ Vaccines
Scout Bio
Zoetis
Merck
Elanco
Virbac
Ceva
Vetoquinol
Segment by Type
Vaccine (Bacteria)
Immune Serum
Antigen & Antibody
Others
Segment by Application
Prevention
Treatment
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Animal Biopharma companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Animal Biopharma Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Vaccine (Bacteria)
1.2.3 Immune Serum
1.2.4 Antigen & Antibody
1.2.5 Others
1.3 Market by Application
1.3.1 Global Animal Biopharma Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Prevention
1.3.3 Treatment
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Animal Biopharma Market Perspective (2019-2030)
2.2 Animal Biopharma Growth Trends by Region
2.2.1 Global Animal Biopharma Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Animal Biopharma Historic Market Size by Region (2019-2024)
2.2.3 Animal Biopharma Forecasted Market Size by Region (2025-2030)
2.3 Animal Biopharma Market Dynamics
2.3.1 Animal Biopharma Industry Trends
2.3.2 Animal Biopharma Market Drivers
2.3.3 Animal Biopharma Market Challenges
2.3.4 Animal Biopharma Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Animal Biopharma Players by Revenue
3.1.1 Global Top Animal Biopharma Players by Revenue (2019-2024)
3.1.2 Global Animal Biopharma Revenue Market Share by Players (2019-2024)
3.2 Global Animal Biopharma Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Animal Biopharma Revenue
3.4 Global Animal Biopharma Market Concentration Ratio
3.4.1 Global Animal Biopharma Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Animal Biopharma Revenue in 2023
3.5 Animal Biopharma Key Players Head office and Area Served
3.6 Key Players Animal Biopharma Product Solution and Service
3.7 Date of Enter into Animal Biopharma Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Animal Biopharma Breakdown Data by Type
4.1 Global Animal Biopharma Historic Market Size by Type (2019-2024)
4.2 Global Animal Biopharma Forecasted Market Size by Type (2025-2030)
5 Animal Biopharma Breakdown Data by Application
5.1 Global Animal Biopharma Historic Market Size by Application (2019-2024)
5.2 Global Animal Biopharma Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Animal Biopharma Market Size (2019-2030)
6.2 North America Animal Biopharma Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Animal Biopharma Market Size by Country (2019-2024)
6.4 North America Animal Biopharma Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Animal Biopharma Market Size (2019-2030)
7.2 Europe Animal Biopharma Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Animal Biopharma Market Size by Country (2019-2024)
7.4 Europe Animal Biopharma Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Animal Biopharma Market Size (2019-2030)
8.2 Asia-Pacific Animal Biopharma Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Animal Biopharma Market Size by Region (2019-2024)
8.4 Asia-Pacific Animal Biopharma Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Animal Biopharma Market Size (2019-2030)
9.2 Latin America Animal Biopharma Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Animal Biopharma Market Size by Country (2019-2024)
9.4 Latin America Animal Biopharma Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Animal Biopharma Market Size (2019-2030)
10.2 Middle East & Africa Animal Biopharma Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Animal Biopharma Market Size by Country (2019-2024)
10.4 Middle East & Africa Animal Biopharma Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Boehringer Ingelheim
11.1.1 Boehringer Ingelheim Company Detail
11.1.2 Boehringer Ingelheim Business Overview
11.1.3 Boehringer Ingelheim Animal Biopharma Introduction
11.1.4 Boehringer Ingelheim Revenue in Animal Biopharma Business (2019-2024)
11.1.5 Boehringer Ingelheim Recent Development
11.2 Invetx
11.2.1 Invetx Company Detail
11.2.2 Invetx Business Overview
11.2.3 Invetx Animal Biopharma Introduction
11.2.4 Invetx Revenue in Animal Biopharma Business (2019-2024)
11.2.5 Invetx Recent Development
11.3 CZ Vaccines
11.3.1 CZ Vaccines Company Detail
11.3.2 CZ Vaccines Business Overview
11.3.3 CZ Vaccines Animal Biopharma Introduction
11.3.4 CZ Vaccines Revenue in Animal Biopharma Business (2019-2024)
11.3.5 CZ Vaccines Recent Development
11.4 Scout Bio
11.4.1 Scout Bio Company Detail
11.4.2 Scout Bio Business Overview
11.4.3 Scout Bio Animal Biopharma Introduction
11.4.4 Scout Bio Revenue in Animal Biopharma Business (2019-2024)
11.4.5 Scout Bio Recent Development
11.5 Zoetis
11.5.1 Zoetis Company Detail
11.5.2 Zoetis Business Overview
11.5.3 Zoetis Animal Biopharma Introduction
11.5.4 Zoetis Revenue in Animal Biopharma Business (2019-2024)
11.5.5 Zoetis Recent Development
11.6 Merck
11.6.1 Merck Company Detail
11.6.2 Merck Business Overview
11.6.3 Merck Animal Biopharma Introduction
11.6.4 Merck Revenue in Animal Biopharma Business (2019-2024)
11.6.5 Merck Recent Development
11.7 Elanco
11.7.1 Elanco Company Detail
11.7.2 Elanco Business Overview
11.7.3 Elanco Animal Biopharma Introduction
11.7.4 Elanco Revenue in Animal Biopharma Business (2019-2024)
11.7.5 Elanco Recent Development
11.8 Virbac
11.8.1 Virbac Company Detail
11.8.2 Virbac Business Overview
11.8.3 Virbac Animal Biopharma Introduction
11.8.4 Virbac Revenue in Animal Biopharma Business (2019-2024)
11.8.5 Virbac Recent Development
11.9 Ceva
11.9.1 Ceva Company Detail
11.9.2 Ceva Business Overview
11.9.3 Ceva Animal Biopharma Introduction
11.9.4 Ceva Revenue in Animal Biopharma Business (2019-2024)
11.9.5 Ceva Recent Development
11.10 Vetoquinol
11.10.1 Vetoquinol Company Detail
11.10.2 Vetoquinol Business Overview
11.10.3 Vetoquinol Animal Biopharma Introduction
11.10.4 Vetoquinol Revenue in Animal Biopharma Business (2019-2024)
11.10.5 Vetoquinol Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Animal Biopharma Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Vaccine (Bacteria)
Table 3. Key Players of Immune Serum
Table 4. Key Players of Antigen & Antibody
Table 5. Key Players of Others
Table 6. Global Animal Biopharma Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 7. Global Animal Biopharma Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 8. Global Animal Biopharma Market Size by Region (2019-2024) & (US$ Million)
Table 9. Global Animal Biopharma Market Share by Region (2019-2024)
Table 10. Global Animal Biopharma Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 11. Global Animal Biopharma Market Share by Region (2025-2030)
Table 12. Animal Biopharma Market Trends
Table 13. Animal Biopharma Market Drivers
Table 14. Animal Biopharma Market Challenges
Table 15. Animal Biopharma Market Restraints
Table 16. Global Animal Biopharma Revenue by Players (2019-2024) & (US$ Million)
Table 17. Global Animal Biopharma Market Share by Players (2019-2024)
Table 18. Global Top Animal Biopharma Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Animal Biopharma as of 2023)
Table 19. Ranking of Global Top Animal Biopharma Companies by Revenue (US$ Million) in 2023
Table 20. Global 5 Largest Players Market Share by Animal Biopharma Revenue (CR5 and HHI) & (2019-2024)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Animal Biopharma Product Solution and Service
Table 23. Date of Enter into Animal Biopharma Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Animal Biopharma Market Size by Type (2019-2024) & (US$ Million)
Table 26. Global Animal Biopharma Revenue Market Share by Type (2019-2024)
Table 27. Global Animal Biopharma Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 28. Global Animal Biopharma Revenue Market Share by Type (2025-2030)
Table 29. Global Animal Biopharma Market Size by Application (2019-2024) & (US$ Million)
Table 30. Global Animal Biopharma Revenue Market Share by Application (2019-2024)
Table 31. Global Animal Biopharma Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 32. Global Animal Biopharma Revenue Market Share by Application (2025-2030)
Table 33. North America Animal Biopharma Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 34. North America Animal Biopharma Market Size by Country (2019-2024) & (US$ Million)
Table 35. North America Animal Biopharma Market Size by Country (2025-2030) & (US$ Million)
Table 36. Europe Animal Biopharma Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 37. Europe Animal Biopharma Market Size by Country (2019-2024) & (US$ Million)
Table 38. Europe Animal Biopharma Market Size by Country (2025-2030) & (US$ Million)
Table 39. Asia-Pacific Animal Biopharma Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 40. Asia-Pacific Animal Biopharma Market Size by Region (2019-2024) & (US$ Million)
Table 41. Asia-Pacific Animal Biopharma Market Size by Region (2025-2030) & (US$ Million)
Table 42. Latin America Animal Biopharma Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 43. Latin America Animal Biopharma Market Size by Country (2019-2024) & (US$ Million)
Table 44. Latin America Animal Biopharma Market Size by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Animal Biopharma Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 46. Middle East & Africa Animal Biopharma Market Size by Country (2019-2024) & (US$ Million)
Table 47. Middle East & Africa Animal Biopharma Market Size by Country (2025-2030) & (US$ Million)
Table 48. Boehringer Ingelheim Company Detail
Table 49. Boehringer Ingelheim Business Overview
Table 50. Boehringer Ingelheim Animal Biopharma Product
Table 51. Boehringer Ingelheim Revenue in Animal Biopharma Business (2019-2024) & (US$ Million)
Table 52. Boehringer Ingelheim Recent Development
Table 53. Invetx Company Detail
Table 54. Invetx Business Overview
Table 55. Invetx Animal Biopharma Product
Table 56. Invetx Revenue in Animal Biopharma Business (2019-2024) & (US$ Million)
Table 57. Invetx Recent Development
Table 58. CZ Vaccines Company Detail
Table 59. CZ Vaccines Business Overview
Table 60. CZ Vaccines Animal Biopharma Product
Table 61. CZ Vaccines Revenue in Animal Biopharma Business (2019-2024) & (US$ Million)
Table 62. CZ Vaccines Recent Development
Table 63. Scout Bio Company Detail
Table 64. Scout Bio Business Overview
Table 65. Scout Bio Animal Biopharma Product
Table 66. Scout Bio Revenue in Animal Biopharma Business (2019-2024) & (US$ Million)
Table 67. Scout Bio Recent Development
Table 68. Zoetis Company Detail
Table 69. Zoetis Business Overview
Table 70. Zoetis Animal Biopharma Product
Table 71. Zoetis Revenue in Animal Biopharma Business (2019-2024) & (US$ Million)
Table 72. Zoetis Recent Development
Table 73. Merck Company Detail
Table 74. Merck Business Overview
Table 75. Merck Animal Biopharma Product
Table 76. Merck Revenue in Animal Biopharma Business (2019-2024) & (US$ Million)
Table 77. Merck Recent Development
Table 78. Elanco Company Detail
Table 79. Elanco Business Overview
Table 80. Elanco Animal Biopharma Product
Table 81. Elanco Revenue in Animal Biopharma Business (2019-2024) & (US$ Million)
Table 82. Elanco Recent Development
Table 83. Virbac Company Detail
Table 84. Virbac Business Overview
Table 85. Virbac Animal Biopharma Product
Table 86. Virbac Revenue in Animal Biopharma Business (2019-2024) & (US$ Million)
Table 87. Virbac Recent Development
Table 88. Ceva Company Detail
Table 89. Ceva Business Overview
Table 90. Ceva Animal Biopharma Product
Table 91. Ceva Revenue in Animal Biopharma Business (2019-2024) & (US$ Million)
Table 92. Ceva Recent Development
Table 93. Vetoquinol Company Detail
Table 94. Vetoquinol Business Overview
Table 95. Vetoquinol Animal Biopharma Product
Table 96. Vetoquinol Revenue in Animal Biopharma Business (2019-2024) & (US$ Million)
Table 97. Vetoquinol Recent Development
Table 98. Research Programs/Design for This Report
Table 99. Key Data Information from Secondary Sources
Table 100. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Animal Biopharma Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Animal Biopharma Market Share by Type: 2023 VS 2030
Figure 3. Vaccine (Bacteria) Features
Figure 4. Immune Serum Features
Figure 5. Antigen & Antibody Features
Figure 6. Others Features
Figure 7. Global Animal Biopharma Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 8. Global Animal Biopharma Market Share by Application: 2023 VS 2030
Figure 9. Prevention Case Studies
Figure 10. Treatment Case Studies
Figure 11. Animal Biopharma Report Years Considered
Figure 12. Global Animal Biopharma Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 13. Global Animal Biopharma Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 14. Global Animal Biopharma Market Share by Region: 2023 VS 2030
Figure 15. Global Animal Biopharma Market Share by Players in 2023
Figure 16. Global Top Animal Biopharma Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Animal Biopharma as of 2023)
Figure 17. The Top 10 and 5 Players Market Share by Animal Biopharma Revenue in 2023
Figure 18. North America Animal Biopharma Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 19. North America Animal Biopharma Market Share by Country (2019-2030)
Figure 20. United States Animal Biopharma Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. Canada Animal Biopharma Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Europe Animal Biopharma Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Europe Animal Biopharma Market Share by Country (2019-2030)
Figure 24. Germany Animal Biopharma Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. France Animal Biopharma Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. U.K. Animal Biopharma Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Italy Animal Biopharma Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Russia Animal Biopharma Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Nordic Countries Animal Biopharma Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Asia-Pacific Animal Biopharma Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Asia-Pacific Animal Biopharma Market Share by Region (2019-2030)
Figure 32. China Animal Biopharma Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Japan Animal Biopharma Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. South Korea Animal Biopharma Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Southeast Asia Animal Biopharma Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. India Animal Biopharma Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Australia Animal Biopharma Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Latin America Animal Biopharma Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Latin America Animal Biopharma Market Share by Country (2019-2030)
Figure 40. Mexico Animal Biopharma Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Brazil Animal Biopharma Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Middle East & Africa Animal Biopharma Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Middle East & Africa Animal Biopharma Market Share by Country (2019-2030)
Figure 44. Turkey Animal Biopharma Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Saudi Arabia Animal Biopharma Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Boehringer Ingelheim Revenue Growth Rate in Animal Biopharma Business (2019-2024)
Figure 47. Invetx Revenue Growth Rate in Animal Biopharma Business (2019-2024)
Figure 48. CZ Vaccines Revenue Growth Rate in Animal Biopharma Business (2019-2024)
Figure 49. Scout Bio Revenue Growth Rate in Animal Biopharma Business (2019-2024)
Figure 50. Zoetis Revenue Growth Rate in Animal Biopharma Business (2019-2024)
Figure 51. Merck Revenue Growth Rate in Animal Biopharma Business (2019-2024)
Figure 52. Elanco Revenue Growth Rate in Animal Biopharma Business (2019-2024)
Figure 53. Virbac Revenue Growth Rate in Animal Biopharma Business (2019-2024)
Figure 54. Ceva Revenue Growth Rate in Animal Biopharma Business (2019-2024)
Figure 55. Vetoquinol Revenue Growth Rate in Animal Biopharma Business (2019-2024)
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed
